Patents by Inventor Lewis Daniel Turner

Lewis Daniel Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-ALKOXYPYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF
    Publication number: 20240002391
    Abstract: 4-Alkoxypyrrolo[2,1-f][1,2,4]triazine compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of 4-alkoxypyrrolo[2,1-f][1,2,4]triazine compounds or analogs thereof, in the treatment of disorders characterized by overexpression of DYRK1A (e.g., cancer, Down syndrome, Alzheimer's disease, diabetes, viral infections, and osteoarthritis).
    Type: Application
    Filed: June 23, 2023
    Publication date: January 4, 2024
    Inventors: Gopi Kumar Mittapalli, Chi Ching Mak, Lewis Daniel Turner, Brian Joseph Hofilena, Ramkrishna Reddy Vakiti, Brian Walter Eastman, David Mark Wallace
  • PYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF
    Publication number: 20230312605
    Abstract: Pyrrolo[2,1-f][1,2,4]triazine compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of pyrrolo[2,1-f][1,2,4]triazine compounds or analogs thereof, in the treatment of disorders characterized by overexpression of DYRK1A (e.g., cancer, Down syndrome, Alzheimer’s disease, diabetes, viral infections, and osteoarthritis).
    Type: Application
    Filed: October 12, 2022
    Publication date: October 5, 2023
    Inventors: Gopi Kumar Mittapalli, Sunil Kumar KC, Chi Ching Mak, Brian Joseph Hofilena, Lewis Daniel Turner, Brian Walter Eastman, Ramkrishna Reddy Vakiti, Joseph Timothy Marakovits
  • 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF
    Publication number: 20230167133
    Abstract: 7H-Pyrrolo[2,3-d]pyrimidine compound for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of 7H-pyrrolo[2,3-d]pyrimidine compounds or analogs thereof, in the treatment of disorders characterized by overexpression of DYRK1A (e.g., cancer, Down syndrome, Alzheimer's disease, diabetes, viral infections, and osteoarthritis).
    Type: Application
    Filed: October 12, 2022
    Publication date: June 1, 2023
    Inventors: Gopi Kumar Mittapalli, Sunil Kumar KC, Chi Ching Mak, Brian Joseph Hofilena, Chandramouli Chiruta, Ramkrishna Reddy Vakiti, Brian Walter Eastman, Joseph Timothy Marakovits, Lewis Daniel Turner